Quick Answer
Sesamin Lipid Markers Randomized Trial has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: Moreover, emerging evidence demonstrates that ferroptosis occurs in endothelial cells, vascular smooth muscle cells, and macrophages within atherosclerotic lesions, suggesting a more direct contribution to plaque vulnerability and vascular dysfunction than other cell death pathways (;;).
Key Takeaways
- 01Moreover, emerging evidence demonstrates that ferroptosis occurs in endothelial cells, vascular smooth muscle cells, and macrophages within atherosclerotic lesions, suggesting a more direct contribution to plaque vulnerability and vascular dysfunction than other cell death pathways (;;). [Chen Xiaoying (2026)]
- 02Accumulating evidence indicates that mA modification and its regulatory enzymes, including METTL3 and FTO, play essential roles in vascular cell function, lipid metabolism, and inflammatory signaling during AS development (). [Chen Xiaoying (2026)]
- 03In this context, recent evidence indicates that SREBF1, traditionally known for its role in lipid metabolism, may exert context-dependent functions under oxidative stress, including regulation of ferroptosis-related antioxidant defenses (;). [Chen Xiaoying (2026)]
- 04Fan and Watanabe, 2022 Libby, 2021 Hansson and Hermansson, 2011 Zhu et al., 2018 Ma et al., 2022 Ouyang et al., 2021 Xu et al., 2024 Atherosclerosis (AS) is a chronic inflammatory vascular disease and the principal pathological basis of cardiovascular and cerebrovascular disorders. [Chen Xiaoying (2026)]
The current Migaku evidence database contains 1 reusable source document for Sesamin Lipid Markers Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation.
- Moreover, emerging evidence demonstrates that ferroptosis occurs in endothelial cells, vascular smooth muscle cells, and macrophages within atherosclerotic lesions, suggesting a more direct contribution to plaque vulnerability and vascular dysfunction than other cell death pathways (;;). [Chen Xiaoying (2026); evidence level 4]
- Accumulating evidence indicates that mA modification and its regulatory enzymes, including METTL3 and FTO, play essential roles in vascular cell function, lipid metabolism, and inflammatory signaling during AS development (). [Chen Xiaoying (2026); evidence level 4]
- In this context, recent evidence indicates that SREBF1, traditionally known for its role in lipid metabolism, may exert context-dependent functions under oxidative stress, including regulation of ferroptosis-related antioxidant defenses (;). [Chen Xiaoying (2026); evidence level 4]
- Fan and Watanabe, 2022 Libby, 2021 Hansson and Hermansson, 2011 Zhu et al., 2018 Ma et al., 2022 Ouyang et al., 2021 Xu et al., 2024 Atherosclerosis (AS) is a chronic inflammatory vascular disease and the principal pathological basis of cardiovascular and cerebrovascular disorders. [Chen Xiaoying (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources